Related Experiment Video

Updated: Aug 23, 2026

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

Multifaceted roles of cyclooxygenase-2 in lung cancer

Karen Riedl1, Kostyantyn Krysan, Mehis Põld

  • 1UCLA Lung Cancer Research Program, Department of Medicine, 37-131 CHS, David Geffen School of Medicine at UCLA, 10833 LeConte Avenue, Los Angeles, CA 90095-1690, USA.

Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|August 7, 2004
PubMed

Insights

Lung cancer, a leading cause of cancer death, shows minimal survival rate improvement. Targeting cyclooxygenase-2 (COX-2) may offer new therapeutic strategies by inhibiting tumor growth and enhancing conventional treatments.

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • Lung cancer remains the leading cause of cancer mortality in the US with a stagnant 5-year survival rate.
  • Cyclooxygenase-2 (COX-2) is frequently overexpressed in lung cancer, contributing to tumor progression, invasion, angiogenesis, and apoptosis resistance.

Purpose of the Study:

  • To explore the role of COX-2 in lung cancer pathogenesis.
  • To investigate the potential of COX-2 inhibitors as therapeutic agents for lung cancer.

Main Methods:

  • Review of existing evidence on COX-2 expression and function in lung cancer.
  • Analysis of preclinical data from animal models.
  • Evaluation of clinical trial results for COX-2 inhibitors in combination therapy.

Main Results:

  • COX-2 inhibitors demonstrated tumor growth inhibition in animal models.
  • Combined therapy with COX-2 inhibitors showed promising responses in Phase II clinical trials.

Conclusions:

  • Understanding COX-2-mediated tumorigenesis and its molecular interactions is crucial for developing novel lung cancer therapies.
  • Targeting COX-2 presents a potential strategy to improve patient outcomes in lung cancer treatment.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...